FundedIQ
Biotechnology

Causeway Sensors: Funding, Investors & Team (Oct 2026)

The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.

www.causewaysensors.com LinkedIn Belfast, United Kingdom 1-10 employees
Analytics Big Data Biotechnology Health Care Health Diagnostics Nanotechnology
Total raised
$2.7M
Rounds
2
Latest
Undisclosed round
Apr 2026

Causeway Sensors has raised $2.7M across 2 funding rounds on record, the most recent an undisclosed round of $670k announced in Apr 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Causeway Sensors Company Profile and Key Stats

Total funding raised
$2.7M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$670k in Apr 2026
Employees
1-10
reported band
Headquarters
Belfast, United Kingdom

Latest funding round on record: Apr 2026.

Causeway Sensors Funding Rounds

Date
Round
Amount
Undisclosed round
$670k
Undisclosed round
$2.0M

Causeway Sensors raised $2.0M in an undisclosed round announced in Mar 2022.

4.1 years later, an undisclosed round of $670k was announced in Apr 2026.

Causeway Sensors Founders and Leadership Team

Name
Role
Contact
Antony Murphy
CEO
—

No contact details are on record for this team yet.

Causeway Sensors Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,352
$4.1M

Causeway Sensors' latest round of $670k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Causeway Sensors in Biotechnology and Belfast

Companies Similar to Causeway Sensors

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

Causeway Sensors Funding FAQs

What does Causeway Sensors do?

The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.

How much funding has Causeway Sensors raised?

Causeway Sensors has raised $2.7M across 2 rounds on record. The most recent is an undisclosed round of $670k announced in Apr 2026.

When did Causeway Sensors last raise funding?

Causeway Sensors' most recent funding round on record is an undisclosed round of $670k, announced in Apr 2026.

Who is the CEO of Causeway Sensors?

Antony Murphy is listed as CEO at Causeway Sensors.

Where is Causeway Sensors headquartered?

Causeway Sensors is based in Belfast, United Kingdom.

How many employees does Causeway Sensors have?

Causeway Sensors is in the 1-10 employee band.

How does Causeway Sensors' funding compare to other Biotechnology startups?

Causeway Sensors' latest round of $670k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Causeway Sensors Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Causeway Sensors is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.